Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty

This publication has 99 references indexed in Scilit:

• Subcutaneous heparin in postangioplasty management: Comparative trial with intravenous heparin
  American Heart Journal, 1993
• Preprocedural anticoagulation does not reduce angioplasty heparin requirements
  American Heart Journal, 1993
• Fish oil supplements for prevention of restenosis after coronary angioplasty
  International Journal of Cardiology, 1992
• Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty
  American Heart Journal, 1991
• The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty
  American Heart Journal, 1990
• A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
  New England Journal of Medicine, 1989
• Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
  American Heart Journal, 1989
• Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids
  New England Journal of Medicine, 1988
• Coronary artery spasm after administration of dextran 40: Implications concerning percutaneous transluminal coronary angioplasty
  American Heart Journal, 1986
• Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.
  Circulation, 1984